432 Identification of clinically relevant pharmacodynamic biomarkers in patients treated with the CDK inhibitor CYC202 (R-roscovitine)
S.R. Green, S. Frame, K. Watt, S. Anderson, I.N. Fleming, D.E. MacCallum, J. Melville, M. Watson, A. Gianella-Borradori, D.P. LaneVolume:
2
Year:
2004
Language:
english
DOI:
10.1016/s1359-6349(04)80440-3
File:
PDF, 145 KB
english, 2004